Beta-lactam-induced Serum Sickness-Like Reaction Pathogenesis Study

Abdelbaset Elzagallaai from Western University conducted a pilot study investigating the pathogenesis of drug-induced serum sickness-like reactions (SSLRs). The research involved 19 patients and 19 healthy controls, using the lymphocyte toxicity assay (LTA) to evaluate the role of reactive drug metabolites. Results indicated a significant concentration-related increase in cell death in patient cells, suggesting bioactivation of the drug is a key step in β-lactam antibiotic-induced SSLRs.

Use Cases

• Investigating the role of reactive metabolites in drug hypersensitivity based on the lymphocyte toxicity assay results.
• Analyzing patient susceptibility to serum sickness-like reactions based on demographic data collected from 19 patients.
• Comparing in vitro toxic responses between patient and control groups based on cell death percentage increase data.

Strengths

• Includes data from 19 patients and 19 matched healthy controls.
• Reports statistically significant (p<0.05) concentration-related findings from the LTA test.

Limitations

• Row count and column-level documentation are absent; field semantics must be inferred after download.
• Data may reflect bias inherent to a single, small-scale pilot study from paperswithcode.
• Last update date is unknown; freshness unverified.

Provenance

Source

Western University

Collection Method

Lymphocyte toxicity assay (LTA) performed on blood samples from recruited patients and healthy controls.